Table 3.
Laboratory evaluation of the cases with AD.
| Female (Total=110) | Male (Total=51) |
Total (Total=161) |
p | |
|---|---|---|---|---|
| APOE genotype n (%) | ||||
| E3/E4 E2/E4 E3/E3 E4/E4 |
8(61.54%) 1(7.69%) 3(23.08%) 1(7.69%) |
5(50%) – 3(30%) 2(20%) |
13(56.52%) 1(4.35%) 6(26.09%) 3(13.04%) |
0.56574 |
| Hippocampal atrophy n (%) | ||||
| Grade 1 Grade 2 Grade 3 |
22(20.00%) 54(49.09%) 34(30.91%) |
6(11.76%) 27(52.94%) 18(35.29%) |
28(17.39%) 81(50.31%) 52(32.30%) |
0.43410 |
| Fazekas scores n (%) | ||||
| Grade 0 Grade 1 Grade 2 |
33(30.00%) 60(54.55%) 17(15.45%) |
13(25.49%) 28(54.90%) 10(19.61%) |
46(28.57%) 88(54.66%) 27(16.77%) |
0.73813 |